BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29779341)

  • 1. [The consensus for differential diagnosis of B cell chronic lymphoproliferative diseases in China (2018 edition)].
    ; ;
    Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):359-365. PubMed ID: 29779341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interpretation of the consensus for diagnosis and differential diagnosis of B cell chronic lymphoproliferative diseases in China (2018 edition)].
    Li ZJ; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):370-371. PubMed ID: 29779343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Expert consensus on diagnosis of B cell chronic lymphoproliferative disorders in China (2014)].
    Hematology Branch of Chinese Medical Association, Hematological Malignancies Professional Committee of China Anti-cancer Association
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):367-70. PubMed ID: 24759033
    [No Abstract]   [Full Text] [Related]  

  • 4. [Possibilities of differential diagnosis of B-cell chronic lymphoproliferative diseases using monoclonal antibodies].
    Samoilova RS
    Gematol Transfuziol; 1990 Jun; 35(6):24-7. PubMed ID: 2203667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for cardiovascular rehabilitation and secondary prevention in China 2018 simplified edition].
    Commitee of Cardiac Rehabilitation and Prevention of Chinese Association of Rehabilitation Medicine
    Zhonghua Nei Ke Za Zhi; 2018 Nov; 57(11):802-810. PubMed ID: 30392235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of polymerase chain reaction (PCR) to detect monoclonality of B-lymphoproliferative disorders at DNA level].
    Wan JH
    Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):242-5. PubMed ID: 2272256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum and immunophenotyping of 653 patients with B-cell chronic lymphoproliferative disorders in China: A single-centre analysis.
    Miao Y; Cao L; Sun Q; Li XT; Wang Y; Qiao C; Wang L; Wang R; Qiu HR; Xu W; Li JY; Wu YJ; Fan L
    Hematol Oncol; 2018 Feb; 36(1):121-127. PubMed ID: 28752619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.
    Cheng S; Chen M; Cai J;
    Oncotarget; 2017 Jan; 8(5):8867-8876. PubMed ID: 27780939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert consensus on multidisciplinary diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2020 edition)].
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):14-20. PubMed ID: 32023692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the diagnosis and treatment of chronic pancreatitis in China (2018 edition).
    Zou WB; Ru N; Wu H; Hu LH; Ren X; Jin G; Wang Z; Du YQ; Cao YN; Zhang L; Chang XY; Zhang RC; Li XB; Shen Y; Li P; Li ZS; Liao Z;
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):103-109. PubMed ID: 30922816
    [No Abstract]   [Full Text] [Related]  

  • 11. Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition).
    Li J; Yuan Y; Yang F; Wang Y; Zhu X; Wang Z; Zheng S; Wan D; He J; Wang J; Ba Y; Bai C; Bai L; Bai W; Bi F; Cai K; Cai M; Cai S; Chen G; Chen K; Chen L; Chen P; Chi P; Dai G; Deng Y; Ding K; Fan Q; Fang W; Fang X; Feng F; Fu C; Fu Q; Gu Y; He Y; Jia B; Jiang K; Lai M; Lan P; Li E; Li D; Li J; Li L; Li M; Li S; Li Y; Li Y; Li Z; Liang X; Liang Z; Lin F; Lin G; Liu H; Liu J; Liu T; Liu Y; Pan H; Pan Z; Pei H; Qiu M; Qu X; Ren L; Shen Z; Sheng W; Song C; Song L; Sun J; Sun L; Sun Y; Tang Y; Tao M; Wang C; Wang H; Wang J; Wang S; Wang X; Wang X; Wang Z; Wu A; Wu N; Xia L; Xiao Y; Xing B; Xiong B; Xu J; Xu J; Xu N; Xu R; Xu Z; Yang Y; Yao H; Ye Y; Yu Y; Yu Y; Yue J; Zhang J; Zhang J; Zhang S; Zhang W; Zhang Y; Zhang Z; Zhang Z; Zhao L; Zhao R; Zhou F; Zhou J; Jin J; Gu J; Shen L
    J Hematol Oncol; 2019 Feb; 12(1):16. PubMed ID: 30764882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of chronic lymphoproliferative disorders in Chinese people. An analysis of 64 cases.
    Kwong YL; Wong KF; Chan LC; Liang RH; Chan JK; Wei D; Chiu EK; Chan CH; Todd D; Chan TK
    Cancer; 1994 Jul; 74(1):174-81. PubMed ID: 8004573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of the immunologic phenotype in the diagnosis of chronic lymphoproliferative syndromes with splenomegaly as the dominant clinical manifestation].
    Silva Rodrigues A; Orfao A; Macedo A; González M; San Miguel J; López-Berges MC; Graça F; Mesonero J; López Borrasca A
    Sangre (Barc); 1990 Oct; 35(5):369-73. PubMed ID: 2291146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expert consensus on treatment of Retroperitoneal tumors in china(Edition 2019)].
    ; ; ; ;
    Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):728-733. PubMed ID: 31648493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [THE COMBINATION OF EXPRESSION OF MARKERS CR1 AND CR2 (CD35/CD21) IN DIAGNOSTIC OF B-CELL LYMPHOPROLIFERATIVE DISEASES].
    Chibisova ON; Burtsev DV; Galstian KM; Lugovskaia GI
    Klin Lab Diagn; 2015 Apr; 60(4):50-2. PubMed ID: 26189291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of the significance of histological, immunohistochemical and clinical data in the diagnosis of lymphoproliferative skin diseases in conformance with a consensus by international experts].
    Belousova IIe; Kazakov DV; Samtsov AV; Kempf W
    Arkh Patol; 2004; 66(2):11-6. PubMed ID: 15154375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Lymphoproliferative Disorders: What's New in the Revised 4th Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms.
    Sundram U
    Adv Anat Pathol; 2019 Mar; 26(2):93-113. PubMed ID: 30199396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chinese National Consensus on diagnosis and management of Barrett's esophagus (BE): revised edition, June 2011, Chongqing, China.
    Fang DC; Lin SR; Huang Q; Yu ZL; Yuan YZ; Chen MH; Bai WY; Chen XX; Zhang J; Li YQ; Zhou LY; Ke MY; Fang XC; Lan Y
    J Dig Dis; 2011 Dec; 12(6):415-9. PubMed ID: 22118689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.